{
    "Trade/Device Name(s)": [
        "BD Veritor System for Rapid Detection of Flu A+B",
        "BD Veritor System for Rapid Detection of Flu A + B",
        "BD Veritor System for Flu A+B"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K112277",
    "Predicate Device Reference 510(k) Number(s)": [
        "K053146",
        "K092698"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "September 30, 2011",
    "Summary Letter Received Date": "October 3, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigen",
        "Influenza B viral nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab",
        "Nasal swab"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "BD Veritor System Reader"
    ],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay",
        "Immunochromatographic assay"
    ],
    "Methodologies": [
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reader"
    ],
    "Document Summary": "FDA 510(k) summary for BD Veritor System for Rapid Detection of Flu A+B, a chromatographic immunoassay for detecting influenza A and B viral antigens from respiratory swabs.",
    "Indications for Use Summary": "A rapid chromatographic immunoassay for qualitative detection and differentiation of influenza A and B viral nucleoprotein antigens from nasopharyngeal and nasal swabs of symptomatic patients as an aid in the diagnosis of influenza A and B viral infections.",
    "fda_folder": "Microbiology"
}